Cargando…

[(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging

BACKGROUND: Scintigraphy using technetium-99m labelled dimercaptosuccinic acid ([(99m)Tc]Tc-DMSA), taken up in the proximal tubules, is the standard in functional imaging of the renal cortex. Recent guidelines recommend performing [(99m)Tc]Tc-DMSA scintigraphy with single photon emission computed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Valind, Kristian, Minarik, David, Garpered, Sabine, Persson, Eva, Jögi, Jonas, Trägårdh, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667166/
https://www.ncbi.nlm.nih.gov/pubmed/37996712
http://dx.doi.org/10.1186/s41824-023-00185-2
_version_ 1785149013511634944
author Valind, Kristian
Minarik, David
Garpered, Sabine
Persson, Eva
Jögi, Jonas
Trägårdh, Elin
author_facet Valind, Kristian
Minarik, David
Garpered, Sabine
Persson, Eva
Jögi, Jonas
Trägårdh, Elin
author_sort Valind, Kristian
collection PubMed
description BACKGROUND: Scintigraphy using technetium-99m labelled dimercaptosuccinic acid ([(99m)Tc]Tc-DMSA), taken up in the proximal tubules, is the standard in functional imaging of the renal cortex. Recent guidelines recommend performing [(99m)Tc]Tc-DMSA scintigraphy with single photon emission computed tomography (SPECT). Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is used for staging and localization of recurrence in prostate cancer. A high renal uptake is often seen on PSMA PET, concordant with known PSMA expression in proximal tubules. This suggests PSMA PET could be used analogous to [(99m)Tc]Tc-DMSA scintigraphy for renal cortical imaging. [(18)F]PSMA-1007 is a promising radiopharmaceutical for this purpose due to low urinary clearance. In this study, we aimed to compare [(18)F]PSMA-1007 PET to [(99m)Tc]Tc-DMSA SPECT regarding split renal uptake and presence of renal uptake defects, in patients with prostate cancer. Three readers interpreted PET and SPECT images regarding presence of renal uptake defects, with each kidney split into cranial, mid and caudal segments. Kidneys were segmented in PET and SPECT images, and left renal uptake as a percentage of total renal uptake was measured. RESULTS: Twenty patients with prostate cancer were included. 2 participants had single kidneys; thus 38 kidneys were evaluated. A total of 29 defects were found on both [(99m)Tc]Tc-DMSA SPECT and [(18)F]PSMA-1007 PET. Cohen’s kappa for concordance regarding presence of any defect was 0.76 on a per-segment basis and 0.67 on a per-kidney basis. Spearman’s r for left renal uptake percentage between [(99m)Tc]Tc-DMSA SPECT and [(18)F]PSMA-1007 PET was 0.95. CONCLUSIONS: [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for detection of uptake defects in this setting. Measurements of split renal function made using [(18)F]PSMA-1007 PET are valid and strongly correlated to measurements made with [(99m)Tc]Tc-DMSA SPECT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41824-023-00185-2.
format Online
Article
Text
id pubmed-10667166
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106671662023-11-24 [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging Valind, Kristian Minarik, David Garpered, Sabine Persson, Eva Jögi, Jonas Trägårdh, Elin Eur J Hybrid Imaging Original Article BACKGROUND: Scintigraphy using technetium-99m labelled dimercaptosuccinic acid ([(99m)Tc]Tc-DMSA), taken up in the proximal tubules, is the standard in functional imaging of the renal cortex. Recent guidelines recommend performing [(99m)Tc]Tc-DMSA scintigraphy with single photon emission computed tomography (SPECT). Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is used for staging and localization of recurrence in prostate cancer. A high renal uptake is often seen on PSMA PET, concordant with known PSMA expression in proximal tubules. This suggests PSMA PET could be used analogous to [(99m)Tc]Tc-DMSA scintigraphy for renal cortical imaging. [(18)F]PSMA-1007 is a promising radiopharmaceutical for this purpose due to low urinary clearance. In this study, we aimed to compare [(18)F]PSMA-1007 PET to [(99m)Tc]Tc-DMSA SPECT regarding split renal uptake and presence of renal uptake defects, in patients with prostate cancer. Three readers interpreted PET and SPECT images regarding presence of renal uptake defects, with each kidney split into cranial, mid and caudal segments. Kidneys were segmented in PET and SPECT images, and left renal uptake as a percentage of total renal uptake was measured. RESULTS: Twenty patients with prostate cancer were included. 2 participants had single kidneys; thus 38 kidneys were evaluated. A total of 29 defects were found on both [(99m)Tc]Tc-DMSA SPECT and [(18)F]PSMA-1007 PET. Cohen’s kappa for concordance regarding presence of any defect was 0.76 on a per-segment basis and 0.67 on a per-kidney basis. Spearman’s r for left renal uptake percentage between [(99m)Tc]Tc-DMSA SPECT and [(18)F]PSMA-1007 PET was 0.95. CONCLUSIONS: [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for detection of uptake defects in this setting. Measurements of split renal function made using [(18)F]PSMA-1007 PET are valid and strongly correlated to measurements made with [(99m)Tc]Tc-DMSA SPECT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41824-023-00185-2. Springer International Publishing 2023-11-24 /pmc/articles/PMC10667166/ /pubmed/37996712 http://dx.doi.org/10.1186/s41824-023-00185-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Valind, Kristian
Minarik, David
Garpered, Sabine
Persson, Eva
Jögi, Jonas
Trägårdh, Elin
[(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title_full [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title_fullStr [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title_full_unstemmed [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title_short [(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
title_sort [(18)f]psma-1007 pet is comparable to [(99m)tc]tc-dmsa spect for renal cortical imaging
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667166/
https://www.ncbi.nlm.nih.gov/pubmed/37996712
http://dx.doi.org/10.1186/s41824-023-00185-2
work_keys_str_mv AT valindkristian 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging
AT minarikdavid 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging
AT garperedsabine 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging
AT perssoneva 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging
AT jogijonas 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging
AT tragardhelin 18fpsma1007petiscomparableto99mtctcdmsaspectforrenalcorticalimaging